Skyrizi 360 MG/2.4 ML on-body 2.4ML
Ended Awarded
- Contract number
- SPE2DB25FWWN9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,830
Award facts
- Contract value 100% obligated
- $11,830.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,830 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SKYRIZI 360 MG/2.4 ML on-body autoinjector units on September 5, 2025, with an ultimate completion date of September 26, 2025. This delivery order represents a non-set-aside competitive award sourced through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999 and extending through December 2026. The product being delivered is SKYRIZI, a specialty dermatological pharmaceutical used for treating inflammatory skin conditions, which aligns with the prime contract's broad scope of supplying medications, vaccines, medical devices, and specialized healthcare commodities to support military and federal healthcare systems.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for Defense Health Agency and military healthcare programs. As a child contract under the larger SPE2DX vehicle, this delivery order demonstrates AmerisourceBergen's continued role in fulfilling specialized pharmaceutical supply needs across the federal medical supply chain. The company's extensive portfolio of federal contract awards reflects its capability to meet competitive procurement requirements while delivering diverse medical products ranging from routine medications to specialty pharmaceuticals across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB25FWWN9?
SPE2DB25FWWN9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FWWN9 worth?
The government has obligated $11,830 on SPE2DB25FWWN9.
Is contract SPE2DB25FWWN9 an order under another contract?
Yes. SPE2DB25FWWN9 is a delivery order under SPE2DB24D2018, an indefinite delivery contract.
Was contract SPE2DB25FWWN9 competed?
The extent of competition for SPE2DB25FWWN9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award